title: Diabetes. Insights from the extended follow-up of the ACCORD trial.
abstract: The ACCORD study investigators have published the results of an extended follow-up of the trial, focused on patients with type 2 diabetes mellitus who had been initially assigned to different intensities of glucose control. These data add to existing knowledge on the benefits of glycemic control in this patient population.
authors.affiliation: The George Institute for Global Health, University of Sydney, Missenden Road, Camperdown, NSW 2050, Sydney, Australia. szoungas@georgeinstitute.org.au
authors.forename: Sophia
authors.initials: S
authors.lastname: Zoungas
authors.forename: Mark
authors.initials: M
authors.lastname: Woodward
mesh_terms: D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D019317:Evidence-Based Medicine; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human